Stockscreener 앱 받기
0.357
2.00%
0.007
시간 외 거래:
.33
-0.027
-7.56%
전일 마감가:
$0.35
열려 있는:
$0.342
하루 거래량:
90,257
Relative Volume:
0.37
시가총액:
$3.35M
수익:
$6.98M
순이익/손실:
$-12.70M
주가수익비율:
-0.0336
EPS:
-10.64
순현금흐름:
$-6.94M
1주 성능:
+1.36%
1개월 성능:
+7.30%
6개월 성능:
-75.88%
1년 성능:
-79.36%
1일 변동 폭
$0.342
$0.38
1주일 범위
$0.33
$0.38
52주 변동 폭
$0.2821
$2.27
Petros Pharmaceuticals Inc Stock (PTPI) Company Profile
명칭
Petros Pharmaceuticals Inc
전화
973-242-0005
주소
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Petros Pharmaceuticals Inc 주식(PTPI)의 최신 뉴스
Petros Pharmaceuticals sets date for 2024 annual meeting - Investing.com
Petros Pharmaceuticals reports high comprehension in drug app study - Investing.com
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - AccessWire
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - StockTitan
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - AccessWire
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
Petros Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Yahoo Finance
A History of Outperforming Analyst Forecasts and Beating the Odds: Petros Pharmaceuticals Inc (PTPI) - SETE News
Analytical Overview: Petros Pharmaceuticals Inc (PTPI)’s Ratios Tell a Financial Story - The Dwinnex
A stock that deserves closer examination: Petros Pharmaceuticals Inc (PTPI) - US Post News
Petros Pharmaceuticals stock hits 52-week low at $0.28 - Investing.com India
Petros Pharmaceuticals stock hits 52-week low at $0.28 By Investing.com - Investing.com Canada
Petros Pharmaceuticals stock hits 52-week low at $0.28 - Investing.com
Petros Pharmaceuticals Second Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
PTPI Stock Earnings: Petros Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 - MSN
Petros Pharmaceuticals (NASDAQ:PTPI) Stock Price Down 10.4% - Defense World
Petros Pharmaceuticals stock hits 52-week low at $0.37 - Investing.com
Joel Baglole - InvestorPlace
Closing Figures: Petros Pharmaceuticals Inc (PTPI)’s Negative Finish at 0.41, Down -3.55 - The Dwinnex
Petros Pharmaceuticals reports promising Web App study - Investing.com
PTPI’s Market Whiplash: -70.74% YTD Decline, -7.41% Plunge in 30 Days - The InvestChronicle
Petros Pharmaceuticals reports promising Web App study - Investing.com India
Petros Pharmaceuticals Inc (NASDAQ:PTPI) stock: Is this a flash in the pan today? - US Post News
Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - AccessWire
Petros Pharmaceuticals' Pivotal Statistically Significant Self Selection Study Shows Stronger Results with Proprietary Technology Application as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil) - StockTitan
Petros Pharma (NASDAQ:PTPI) Stock Quotes, Forecast and News Summary - Benzinga
Get in on Petros Pharmaceuticals Inc’s (PTPI) buy-in window today! - SETE News
Financial Metrics Exploration: Understanding Petros Pharmaceuticals Inc (PTPI) Through Ratios - The Dwinnex
Petros reports successful study for STENDRA OTC switch By Investing.com - Investing.com Canada
Petros Pharmaceuticals Inc Inc. (PTPI) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Petros reports successful study for STENDRA OTC switch - Investing.com
Petros reports successful study for STENDRA OTC switch - Investing.com India
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance - AccessWire
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance - StockTitan
Petros Pharmaceuticals’ STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance - Yahoo Finance
Quarterly Metrics: Quick and Current Ratios for Petros Pharmaceuticals Inc (PTPI) – DWinneX - The Dwinnex
Can you still get a good price for Petros Pharmaceuticals Inc (PTPI) Shares at this point? - US Post News
Pioneering change: male contraceptives and the coming OTC revolution - Interesting Engineering
The future of health: male contraceptives and OTC innovation - Interesting Engineering
PTPI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle
Petros Pharmaceuticals Inc (PTPI)'s Market Momentum: Closing Strong at 0.41, Down -2.50 – DWinneX - The Dwinnex
Petros Pharmaceuticals Inc (PTPI) did well last session? – US Post News - US Post News
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros ... - AOL
'The Prescription Erectile Dysfunction Market Could Triple if an ED Therapy Becomes Available - The Bharat Express News
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros ... - TradingView
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says - Yahoo Finance
Stock Surge: Petros Pharmaceuticals Inc (PTPI) Closes at 0.46, Marking a -13.70 Increase/Decrease – DWinneX - The Dwinnex
Healthy Upside Potential: Petros Pharmaceuticals Inc (PTPI) – Sete News - SETE News
Why Broadcom Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving PremarketBroadcom (NASDAQ ... - Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday - InvestorPlace
COMPASS Pathways (NASDAQ:CMPS) & Petros Pharmaceuticals (NASDAQ:PTPI) Critical Contrast - Defense World
Petros Pharmaceuticals Inc (PTPI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.23%
0.18%
자본화:
|
볼륨(24시간):